Published: Fri, June 02, 2017
Money | By Armando Alvarado

GW Henssler & Associates Ltd. Invests $10.10 Million in Gilead Sciences, Inc. (GILD)

It is positive, as 26 investors sold BLMN shares while 67 reduced holdings. Vetr raised shares of Gilead Sciences from a "buy" rating to a "strong-buy" rating and set a $74.58 price target for the company in a research report on Tuesday, April 18th. On Tuesday, March 29 the stock rating was upgraded by Raymond James to "Outperform". Wells Fargo maintained the stock with "Market Perform" rating in Friday, December 4 report. Stifel Nicolaus initiated the stock with "Buy" rating in Monday, November 14 report.

The company's consensus rating on Reuter's scale improved from 2.64 to 2.77 during a month. Jefferies Group LLC reduced their price target on shares of Gilead Sciences from $83.00 to $83.00 and set a "neutral" rating on the stock in a research report on Wednesday, February 8th. The institutional investor held 1.59 million shares of the health care company at the end of 2016Q4, valued at $114.07 million, down from 1.65M at the end of the previous reported quarter. The firm has a market cap of $84.44 billion, a P/E ratio of 6.83 and a beta of 1.11.

The Timken Company (TKR) has a value of $47.15 per share, noted a price change of 2.17% in last trade session. About 5 shares traded. It has underperformed by 38.50% the S&P500. Eleven analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has assigned a strong buy rating to the company. Therefore 100% are positive. Analysts have placed a $78.59 price target on Gilead Sciences, Inc., suggesting a 21.11% gain from recent close. (NASDAQ:GILD) on Wednesday, January 20 with "Outperform" rating. Over the short term, some market observers may have noticed that Gilead Sciences, Inc. has a 0.78% short float with 15 days to cover.

All things being equal, stocks with higher earnings-per-share growth rates are generally more desirable than those with slower earnings-per-share growth rates. (NASDAQ:GILD) has "Buy" rating given on Thursday, September 22 by Berenberg. Crow Point Prns reported 0.01% in Gilead Sciences, Inc. The firm has "Buy" rating given on Thursday, February 25 by Citigroup. The rating was initiated by Gabelli on Wednesday, June 1 with "Buy". The rating was maintained by RBC Capital Markets with "Outperform" on Monday, October 3. The Argentiere Capital Ag holds 75,192 shares with $5.38 million value, down from 200,000 last quarter.

Investors of record on Friday, June 16th will be issued a $0.52 dividend. Its down 0.28, from 1.37 in 2016Q3. It fall, as 32 investors sold JNS shares while 76 reduced holdings. Capital Fund Management S.A. increased its position in shares of Gilead Sciences by 77.4% in the third quarter. The funds in our partner's database now hold: 950.84 million shares, up from 944.29 million shares in 2016Q3. Virtu Ltd holds 5,121 shares or 0.04% of its portfolio. Tocqueville Asset Mgmt Limited Partnership invested 0.09% in Gilead Sciences, Inc. Barclays PLC reaffirmed an "overweight" rating and issued a $85.00 price objective on shares of Gilead Sciences in a research note on Wednesday, May 3rd. The hedge fund run by Brian C. Freckmann held 780,762 shares of the consumer services company at the end of 2016Q4, valued at $3.85 million, up from 283,241 at the end of the previous reported quarter. Ellington Management Group Incorporated Ltd Com holds 0.03% of its portfolio in Meet Group Inc (NASDAQ:MEET) for 36,800 shares.

Point72 Asia (Hong Kong) Limited accumulated 12,602 shares or 0.9% of the stock. Century owns 6.46 million shares for 0.5% of their portfolio. Busey Company has invested 0.51% in Gilead Sciences, Inc. (NASDAQ:GILD). Kcg has invested 0.11% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD) or 3,827 shares. (NASDAQ:GILD). Paradigm Ltd Company has 1.53% invested in Gilead Sciences, Inc. (NASDAQ:GILD). 99,569 are held by Sumitomo Mitsui Asset Mgmt Limited. $1.41 million worth of Gilead Sciences, Inc. Gilead Sciences also saw unusually large options trading activity on Wednesday. (NASDAQ:GILD) on Wednesday, February 1. $5.40M worth of Gilead Sciences, Inc. California Pub Employees Retirement Systems stated it has 3.32M shares or 0.4% of all its holdings.

Anthony Weiner pleads guilty to sexting North Carolina teen, reports say
Huma Abedin , a top aide to Hillary Clinton , reportedly filed for divorce from Weiner on Friday, hours after the guilty plea. Weiner told the website he was "filled with regret and heartbroken", but said he had also been the subject of a hoax.

Since January 3, 2017, it had 0 insider buys, and 9 sales for $28.57 million activity. Another trade for 5,000 shares valued at $337,392 was sold by Alton Gregg H. Bank & Trust Of Montreal Can holds 0% of its portfolio in PrivateBancorp Inc (NASDAQ:PVTB) for 63,649 shares. Norges Bank purchased a new stake in Gilead Sciences during the fourth quarter worth approximately $997,048,000.

In other news, Director John Francis Cogan sold 9,943 shares of the stock in a transaction dated Tuesday, May 9th.

Carlson Capital LP increased Linear Technology Corp (NASDAQ:LLTC) stake by 1.73M shares to 2.34M valued at $145.90 million in 2016Q4. It also upped Toro Co. Following the transaction, the executive vice president now owns 117,988 shares of the company's stock, valued at approximately $7,961,830.24. Nvr Inc. (NYSE:NVR) was raised too. Gilead Sciences has $137 highest and $87 lowest target. (NASDAQ:GILD) rating on Wednesday, July 29. They expect $2.13 earnings per share, down 29.70% or $0.90 from last year's $3.03 per share. GILD's profit will be $2.80 billion for 7.58 P/E if the $2.13 EPS becomes a reality. Going toward to the 50-day, we can see that shares are now trading -2.91% off of that figure. Hanson Mcclain owns 113 shares. Old National Bancorp (NASDAQ:ONB) has risen 28.89% since June 2, 2016 and is uptrending. It has outperformed by 29.85% the S&P500. The company was downgraded on Friday, April 29 by Maxim Group.

Investors sentiment increased to 1.1 in Q4 2016. Kingdon Cap Mngmt Limited Co invested in 175,000 shares or 0.15% of the stock.

Among 12 analysts covering Bloomin' Brands (NASDAQ:BLMN), 2 have Buy rating, 1 Sell and 9 Hold. Its up 0.28, from 0.82 in 2016Q3. Alps Advisors Inc owns 9,226 shares. 48 funds opened positions while 61 raised stakes. Snow LP accumulated 327,560 shares. Aviance Capital Prtnrs Ltd Llc holds 0.4% or 15,719 shares in its portfolio.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Like this: